192 related articles for article (PubMed ID: 27670623)
1. The microbial epigenome in metabolic syndrome.
Remely M; Haslberger AG
Mol Aspects Med; 2017 Apr; 54():71-77. PubMed ID: 27670623
[TBL] [Abstract][Full Text] [Related]
2. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.
Gallardo-Becerra L; Cornejo-Granados F; García-López R; Valdez-Lara A; Bikel S; Canizales-Quinteros S; López-Contreras BE; Mendoza-Vargas A; Nielsen H; Ochoa-Leyva A
Microb Cell Fact; 2020 Mar; 19(1):61. PubMed ID: 32143621
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the gut microbiome and plasma short-chain fatty acid profiles in a spontaneous mouse model of metabolic syndrome.
Nishitsuji K; Xiao J; Nagatomo R; Umemoto H; Morimoto Y; Akatsu H; Inoue K; Tsuneyama K
Sci Rep; 2017 Nov; 7(1):15876. PubMed ID: 29158587
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis.
Kumar H; Lund R; Laiho A; Lundelin K; Ley RE; Isolauri E; Salminen S
mBio; 2014 Dec; 5(6):. PubMed ID: 25516615
[TBL] [Abstract][Full Text] [Related]
5. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
Chen B; Sun L; Zhang X
J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
[TBL] [Abstract][Full Text] [Related]
6. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome.
van der Vossen EWJ; Bastos D; Stols-Gonçalves D; de Goffau MC; Davids M; Pereira JPB; Li Yim AYF; Henneman P; Netea MG; de Vos WM; de Jonge W; Groen AK; Nieuwdorp M; Levin E
Gut Microbes; 2021; 13(1):1993513. PubMed ID: 34747338
[TBL] [Abstract][Full Text] [Related]
7. Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics.
Li D; Li Y; Yang S; Lu J; Jin X; Wu M
Biomed Pharmacother; 2022 Sep; 153():113290. PubMed ID: 35724509
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
9. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
[TBL] [Abstract][Full Text] [Related]
10. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of gut microbiota and its response to a Chinese Herbal Formula in elder patients with metabolic syndrome.
Ni Y; Mu C; He X; Zheng K; Guo H; Zhu W
Drug Discov Ther; 2018; 12(3):161-169. PubMed ID: 29998997
[TBL] [Abstract][Full Text] [Related]
12. Obesity: Gut microbiota, host genetics and diet interact to affect the risk of developing obesity and the metabolic syndrome.
Greenhill C
Nat Rev Endocrinol; 2015 Nov; 11(11):630. PubMed ID: 26346953
[No Abstract] [Full Text] [Related]
13. The Gut Microbiota and their Metabolites: Potential Implications for the Host Epigenome.
Mischke M; Plösch T
Adv Exp Med Biol; 2016; 902():33-44. PubMed ID: 27161349
[TBL] [Abstract][Full Text] [Related]
14. Impact of different hypercaloric diets on obesity features in rats: a metagenomics and metabolomics integrative approach.
Gual-Grau A; Guirro M; Mayneris-Perxachs J; Arola L; Boqué N
J Nutr Biochem; 2019 Sep; 71():122-131. PubMed ID: 31336215
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Emulsifier-Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low-Grade Inflammation in Low-Fat Diet Fed Mice.
Jiang Z; Zhao M; Zhang H; Li Y; Liu M; Feng F
Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29131494
[TBL] [Abstract][Full Text] [Related]
16. New insight into the mechanism of POP-induced obesity: Evidence from DDE-altered microbiota.
Liang Y; Liu D; Zhan J; Luo M; Han J; Wang P; Zhou Z
Chemosphere; 2020 Apr; 244():125123. PubMed ID: 32050320
[TBL] [Abstract][Full Text] [Related]
17. Nutritionally Attenuating the Human Gut Microbiome To Prevent and Manage Metabolic Syndrome.
Louis-Jean S; Martirosyan D
J Agric Food Chem; 2019 Nov; 67(46):12675-12684. PubMed ID: 31661963
[TBL] [Abstract][Full Text] [Related]
18. Effects of a Diet Based on Foods from Symbiotic Agriculture on the Gut Microbiota of Subjects at Risk for Metabolic Syndrome.
Turroni S; Petracci E; Edefonti V; Giudetti AM; D'Amico F; Paganelli L; Giovannetti G; Del Coco L; Fanizzi FP; Rampelli S; Guerra D; Rengucci C; Bulgarelli J; Tazzari M; Pellegrini N; Ferraroni M; Nanni O; Serra P
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34204572
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the microbiome, metabolome, and lipidome of obese and non-obese horses.
Coleman MC; Whitfield-Cargile CM; Madrigal RG; Cohen ND
PLoS One; 2019; 14(4):e0215918. PubMed ID: 31013335
[TBL] [Abstract][Full Text] [Related]
20. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
